Research ArticleAccepted Articles
Open Access
Long-term opioid therapy among patients with systemic lupus erythematosus in the community. A Lupus Midwest Network study
Gabriel Figueroa-Parra, Molly M. Jeffery, Jesse Y. Dabit, Baptiste Chevet, Maria O. Valenzuela-Almada, Mehmet Hocaoglu, Shirley-Ann Osei-Onomah, Shaheen Kurani, Sebastian Vallejo, Sara J. Achenbach, W. Michael Hooten, Kamil E. Barbour, Cynthia S. Crowson and Alí Duarte-García
The Journal of Rheumatology November 2022, jrheum.220822; DOI: https://doi.org/10.3899/jrheum.220822
Gabriel Figueroa-Parra
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Molly M. Jeffery
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Jesse Y. Dabit
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Baptiste Chevet
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Maria O. Valenzuela-Almada
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Mehmet Hocaoglu
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Shirley-Ann Osei-Onomah
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Shaheen Kurani
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Sebastian Vallejo
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Sara J. Achenbach
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
W. Michael Hooten
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Kamil E. Barbour
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Cynthia S. Crowson
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Alí Duarte-García
Funding and Disclaimer: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. J.Y. Dabit, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. M.O. Valenzuela-Almada, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M. Hocaoglu, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Competing interests: Alí Duarte-García is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past three years, Dr. Jeffery has received unrelated grant funding from the Agency for Healthcare Research and Quality, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the American Cancer Society, and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. The rest of the authors have nothing to disclose. Address correspondence to Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Long-term opioid therapy among patients with systemic lupus erythematosus in the community. A Lupus Midwest Network study
Gabriel Figueroa-Parra, Molly M. Jeffery, Jesse Y. Dabit, Baptiste Chevet, Maria O. Valenzuela-Almada, Mehmet Hocaoglu, Shirley-Ann Osei-Onomah, Shaheen Kurani, Sebastian Vallejo, Sara J. Achenbach, W. Michael Hooten, Kamil E. Barbour, Cynthia S. Crowson, Alí Duarte-García
The Journal of Rheumatology Nov 2022, jrheum.220822; DOI: 10.3899/jrheum.220822
Accepted manuscript
Long-term opioid therapy among patients with systemic lupus erythematosus in the community. A Lupus Midwest Network study
Gabriel Figueroa-Parra, Molly M. Jeffery, Jesse Y. Dabit, Baptiste Chevet, Maria O. Valenzuela-Almada, Mehmet Hocaoglu, Shirley-Ann Osei-Onomah, Shaheen Kurani, Sebastian Vallejo, Sara J. Achenbach, W. Michael Hooten, Kamil E. Barbour, Cynthia S. Crowson, Alí Duarte-García
The Journal of Rheumatology Nov 2022, jrheum.220822; DOI: 10.3899/jrheum.220822